These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes. Crane L, Anastassiadou M, El Hage S, Stigliani JL, Baziard-Mouysset G, Payard M, Leger JM, Bizot-Espiard JG, Ktorza A, Caignard DH, Renard P. Bioorg Med Chem; 2006 Nov 15; 14(22):7419-33. PubMed ID: 16889967 [Abstract] [Full Text] [Related]
15. Development of Fibrates as Important Scaffolds in Medicinal Chemistry. Giampietro L, Ammazzalorso A, Amoroso R, De Filippis B. ChemMedChem; 2019 Jun 05; 14(11):1051-1066. PubMed ID: 30957432 [Abstract] [Full Text] [Related]
16. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. Henke BR, Blanchard SG, Brackeen MF, Brown KK, Cobb JE, Collins JL, Harrington WW, Hashim MA, Hull-Ryde EA, Kaldor I, Kliewer SA, Lake DH, Leesnitzer LM, Lehmann JM, Lenhard JM, Orband-Miller LA, Miller JF, Mook RA, Noble SA, Oliver W, Parks DJ, Plunket KD, Szewczyk JR, Willson TM. J Med Chem; 1998 Dec 03; 41(25):5020-36. PubMed ID: 9836620 [Abstract] [Full Text] [Related]
17. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents. Sashidhara KV, Palnati GR, Dodda RP, Sonkar R, Khanna AK, Bhatia G. Eur J Med Chem; 2012 Nov 03; 57():302-10. PubMed ID: 23078966 [Abstract] [Full Text] [Related]
19. Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents. Mokale SN, Palkar AD, Dube PN, Sakle NS, Miniyar PB. Bioorg Med Chem Lett; 2016 Jan 15; 26(2):272-276. PubMed ID: 26707395 [Abstract] [Full Text] [Related]